Literature DB >> 25586097

Heparanase is involved in proliferation and invasion of ovarian cancer cells.

Haiyan Zheng1, Jian Ruan2, Peng Zhao3, Shiping Chen1, Linglan Pan1, Jianqiao Liu1.   

Abstract

Heparanase(HPSE), an endo-β -D-glucuronidase, is found overexpressed in Ovarian cancer (OC). The purpose of our work was to investigate primitively the possible role of HPSE in the development of OC. In this study, RNA interference (RNAi) with a HPSE small hairpin RNAs(HPSE-shRNA) and plasmid with HPSE were used to identify the effects of HPSE on the regulation of malignant behaviors of OC. OV-90 and SKOV3 were selected as a cell model in vitro and in vivo. The results showed that down-regulation of HPSE can significantly inhibit the proliferative and invasive ability of SKOV3 cells, and up-regulation of HPSE in OV-90 cells showed the opposite effects. Compared with the parental OC cells, HPSE silencing cells exhibited attenuated capacities in developing tumor in nude mice, while the growth tumors xenografts derived from these cells were dramatically regressed. In conclusion, our results suggest that HPSE contributes to the proliferation and metastasis of OC and HPSE might be a potent molecular target for OC treatment.

Entities:  

Keywords:  Ovarian cancer; heparanase; invasion; proliferation

Mesh:

Substances:

Year:  2015        PMID: 25586097     DOI: 10.3233/CBM-150459

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN: 1574-0153            Impact factor:   4.388


  6 in total

1.  MicroRNA-219a-2-3p modulates the proliferation of thyroid cancer cells via the HPSE/cyclin D1 pathway.

Authors:  Chuanjia Yang; Siyang Zhang; Xiaoying Chang; Yonglian Huang; Dongxu Cui; Zhen Liu
Journal:  Exp Ther Med       Date:  2021-04-20       Impact factor: 2.447

2.  PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samples.

Authors:  Boris Winterhoff; Luisa Freyer; Edward Hammond; Shailendra Giri; Susmita Mondal; Debarshi Roy; Attila Teoman; Sally A Mullany; Robert Hoffmann; Antonia von Bismarck; Jeremy Chien; Matthew S Block; Michael Millward; Darryn Bampton; Keith Dredge; Viji Shridhar
Journal:  Eur J Cancer       Date:  2015-03-05       Impact factor: 9.162

3.  DNA Methylation Targets Influenced by Bisphenol A and/or Genistein Are Associated with Survival Outcomes in Breast Cancer Patients.

Authors:  Rohit R Jadhav; Julia Santucci-Pereira; Yao V Wang; Joseph Liu; Theresa D Nguyen; Jun Wang; Sarah Jenkins; Jose Russo; Tim H-M Huang; Victor X Jin; Coral A Lamartiniere
Journal:  Genes (Basel)       Date:  2017-05-15       Impact factor: 4.096

4.  Gemcitabine-induced heparanase promotes aggressiveness of pancreatic cancer cells via activating EGFR signaling.

Authors:  Jin-Wen Song; Ying-Xia Tan; Su-Bo Li; Shi-Kun Zhang; Lu-Ming Wan; Shou-Ping Ji; Hong Zhou; Zhi-Hang Zhou; Feng Gong
Journal:  Oncotarget       Date:  2017-04-07

Review 5.  Heparan Sulfate and Heparan Sulfate Proteoglycans in Cancer Initiation and Progression.

Authors:  Arvindhan Nagarajan; Parmanand Malvi; Narendra Wajapeyee
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-24       Impact factor: 5.555

Review 6.  Heparan Sulfate Proteoglycan Signaling in Tumor Microenvironment.

Authors:  Valeria De Pasquale; Luigi Michele Pavone
Journal:  Int J Mol Sci       Date:  2020-09-09       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.